Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-005157
Filing Date
2023-02-28
Accepted
2023-02-28 16:39:17
Documents
6
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 rgnx-s8-2023-02-28.htm S-8 104361
2 EX-5.1 rgnx-ex5_1.htm EX-5 9795
3 EX-23.1 rgnx-ex23_1.htm EX-23 3169
4 EX-FILING FEES rgnx-exfiling_fees.htm EX-FILING FEES 42299
5 GRAPHIC img252287865_0.jpg GRAPHIC 4575
6 GRAPHIC img252287865_1.jpg GRAPHIC 3417
  Complete submission text file 0000950170-23-005157.txt   172074
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270116 | Film No.: 23686233
SIC: 2836 Biological Products, (No Diagnostic Substances)